and no opportunity for earlier response Rising INR, routine warfarin dosage adjustment made promptly; warfarin loading dose appropriate or drug interactions noted for dosage adjustment but still ...

and no opportunity for earlier response Rising INR, routine warfarin dosage adjustment made promptly; warfarin loading dose appropriate or drug interactions noted for dosage adjustment but still ...

Guidance around complete revascularization and intracoronary imaging is strengthened, and Impella gets a recommendation.

Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...

Shorla Oncology (?Shorla'), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, ...

Because warfarin is metabolized by both CYP2C9 and CYP3A4, consider use of other anti-coagulants instead of warfarin in patients receiving IMKELDI who require anticoagulation. Imatinib is a CYP3A ...

The regular testing, monitoring and dosage adjustments required in warfarin treatment repeatedly ... and concerns about future health alongside worries and restrictions about anticoagulation treatment ...

Key opinion leaders explore approaches to dose modifications or treatment pauses due to side effects, including examples ...

Burchfield, MD, and other participants discussed their experiences with the frontline combination regimens for advanced renal ...

Oral anticoagulation is the most effective intervention for the prevention of ischaemic stroke in people with atrial ...